Articles published by Recursion Pharmaceuticals
![](https://ml.globenewswire.com/media/9c3f7e67-3394-4aee-b77d-68f288ea03a7/small/recursion-logo-jpg.jpg)
CORRECTION - Recursion Provides Business Updates and Reports Second Quarter 2024 Financial Results
August 08, 2024
Via GlobeNewswire
Tickers
RXRX
![](https://ml.globenewswire.com/media/9c3f7e67-3394-4aee-b77d-68f288ea03a7/small/recursion-logo-jpg.jpg)
Recursion Provides Business Updates and Reports Second Quarter 2024 Financial Results
August 08, 2024
Via GlobeNewswire
Tickers
RXRX
![](https://www.globenewswire.com/Content/Images/intrado.png)
Via GlobeNewswire
Tickers
RXRX
![](https://www.globenewswire.com/Content/Images/intrado.png)
Recursion to Report Second Quarter 2024 Business Updates and Financial Results on August 8th
August 05, 2024
Via GlobeNewswire
Tickers
RXRX
![](https://www.globenewswire.com/Content/Images/intrado.png)
Via GlobeNewswire
Tickers
RXRX
![](https://www.globenewswire.com/Content/Images/intrado.png)
Via GlobeNewswire
Tickers
RXRX
![](https://www.globenewswire.com/Content/Images/intrado.png)
Via GlobeNewswire
Tickers
RXRX
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://www.globenewswire.com/Content/Images/intrado.png)
Via GlobeNewswire
Tickers
RXRX
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://ml.globenewswire.com/media/9c3f7e67-3394-4aee-b77d-68f288ea03a7/small/recursion-logo-jpg.jpg)
Via GlobeNewswire
Tickers
RXRX
![](https://www.globenewswire.com/Content/Images/intrado.png)
Via GlobeNewswire
Tickers
RXRX
![](https://www.globenewswire.com/Content/Images/intrado.png)
Via GlobeNewswire
Tickers
RXRX
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://www.globenewswire.com/Content/Images/intrado.png)
Recursion to Participate in Upcoming Investor Conference
April 02, 2024
Via GlobeNewswire
Tickers
RXRX
![](https://www.globenewswire.com/Content/Images/intrado.png)
Via GlobeNewswire
Tickers
RXRX
![](https://www.globenewswire.com/Content/Images/intrado.png)
Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community
March 01, 2024
Via GlobeNewswire
Tickers
RXRX
![](https://www.globenewswire.com/Content/Images/intrado.png)
Recursion to Participate in Upcoming Investor Conferences
March 01, 2024
Via GlobeNewswire
Tickers
RXRX
![](https://ml.globenewswire.com/media/9c3f7e67-3394-4aee-b77d-68f288ea03a7/small/recursion-logo-jpg.jpg)
Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results
February 27, 2024
Via GlobeNewswire
Tickers
RXRX
![](https://www.globenewswire.com/Content/Images/intrado.png)
Recursion to Host Public L(earnings) Call on February 27
February 20, 2024
Via GlobeNewswire
Tickers
RXRX
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://www.globenewswire.com/Content/Images/intrado.png)
Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference
January 08, 2024
Via GlobeNewswire
Tickers
RXRX
![](https://www.globenewswire.com/Content/Images/intrado.png)
Recursion to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8
January 03, 2024
Via GlobeNewswire
Tickers
RXRX
![](https://www.globenewswire.com/Content/Images/intrado.png)
Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry
December 20, 2023
Via GlobeNewswire
Tickers
RXRX
![](https://www.globenewswire.com/Content/Images/intrado.png)
Bayer and Recursion Focus Research Collaboration on Oncology
November 09, 2023
Via GlobeNewswire
Tickers
RXRX
![](https://ml.globenewswire.com/media/9c3f7e67-3394-4aee-b77d-68f288ea03a7/small/recursion-logo-jpg.jpg)
Recursion Provides Business Updates and Reports Third Quarter 2023 Financial Results
November 09, 2023
Via GlobeNewswire
Tickers
RXRX
![](https://www.globenewswire.com/Content/Images/intrado.png)
Recursion to Participate in Upcoming Investor Conference
November 02, 2023
Via GlobeNewswire
Tickers
RXRX
![](https://www.globenewswire.com/Content/Images/intrado.png)
Recursion to Participate in Upcoming Investor Conferences
September 05, 2023
Via GlobeNewswire
Tickers
RXRX
![](https://www.globenewswire.com/Content/Images/intrado.png)
Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection
September 05, 2023
Via GlobeNewswire
Tickers
RXRX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.